Trials / Conditions / Glucocerebrosidase Deficiency Disease
Glucocerebrosidase Deficiency Disease
3 registered clinical trials studyying Glucocerebrosidase Deficiency Disease — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | A Study of the Efficacy and Safety of Eliglustat Tartrate (Genz-112638) in Type 1 Gaucher Patients NCT00358150 | Genzyme, a Sanofi Company | Phase 2 |
| Completed | Safety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher Disease NCT00364858 | Genzyme, a Sanofi Company | Phase 4 |
| Recruiting | International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry NCT00358943 | Genzyme, a Sanofi Company | — |